Novolog and Sputum increased - a phase IV clinical study of FDA data

Summary:

Sputum increased is reported as a side effect among people who take Novolog (insulin aspart recombinant), especially for people who are male, 60+ old, also take Cayston, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Sputum increased when taking Novolog. It is created by eHealthMe based on reports of 55,653 people who have side effects when taking Novolog from the FDA, and is updated regularly.

What is Novolog?

Novolog has active ingredients of insulin aspart recombinant. It is often used in diabetes. eHealthMe is studying from 56,160 Novolog users. Check the latest studies of Novolog.

What is Sputum increased?

Sputum increased is found to be associated with 428 drugs and 355 conditions by eHealthMe. Check the latest studies of Sputum increased.

On Jul, 07, 2026

55,653 people reported to have side effects when taking Novolog.
Among them, 24 people (0.04%) have Sputum increased.

Among these 24 people:

What is the gender of people who have Sputum increased when taking Novolog? *

female: 27.78 %
male: 72.22 %

What is the age of people who have Sputum increased when taking Novolog? *

What are other drugs people take besides Novolog? *

What are other side effects people have besides Sputum increased? *

Cough: 22 people, 91.67%
Dyspnea (difficult or laboured breathing): 20 people, 83.33%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 16 people, 66.67%
Fever: 16 people, 66.67%
Chest Pain: 13 people, 54.17%
Wheezing (a high-pitched whistling sound made while you breath): 11 people, 45.83%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 11 people, 45.83%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 37.50%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 8 people, 33.33%
Weight Decreased: 8 people, 33.33%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 19 people, 79.17%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 16 people, 66.67%
Cystic Fibrosis Related Diabetes: 10 people, 41.67%
Cough: 9 people, 37.50%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 9 people, 37.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 37.50%
Pulmonary Congestion (congestion in the lungs): 9 people, 37.50%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 8 people, 33.33%
High Blood Pressure: 8 people, 33.33%
Joint Pain: 7 people, 29.17%

* Approximation only. Some reports may have incomplete information.

Do you take Novolog and have Sputum increased?

- Check whether Sputum increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novolog:

Novolog (56,160 reports)

Browse all side effects of Novolog:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sputum increased:

Sputum increased (428 drugs)

Browse all the conditions that are associated with Sputum increased:

Sputum increased (355 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novolog) and Novolog (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.